TETRACYCLIC COMPOUND

A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(me...

Full description

Saved in:
Bibliographic Details
Main Authors ONO, Yoshiyuki, ISHII, Nobuya, MORIKAMI, Kenji, KAWADA, Hatsuo, KATO, Yasuharu, KINOSHITA, Kazutomo, ITO, Toshiya, OIKAWA, Nobuhiro, PARK, MinJeong, FURUICHI, Noriyuki, EMURA, Takashi, SAKAMOTO, Hiroshi, ASOH, Kohsuke, HONG, WooSang
Format Patent
LanguageEnglish
Published 29.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(meanings of the symbols that are included in the formula are as given in the specification).
AbstractList A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(meanings of the symbols that are included in the formula are as given in the specification).
Author HONG, WooSang
KATO, Yasuharu
FURUICHI, Noriyuki
ITO, Toshiya
ONO, Yoshiyuki
MORIKAMI, Kenji
ASOH, Kohsuke
PARK, MinJeong
ISHII, Nobuya
SAKAMOTO, Hiroshi
KAWADA, Hatsuo
KINOSHITA, Kazutomo
OIKAWA, Nobuhiro
EMURA, Takashi
Author_xml – fullname: ONO, Yoshiyuki
– fullname: ISHII, Nobuya
– fullname: MORIKAMI, Kenji
– fullname: KAWADA, Hatsuo
– fullname: KATO, Yasuharu
– fullname: KINOSHITA, Kazutomo
– fullname: ITO, Toshiya
– fullname: OIKAWA, Nobuhiro
– fullname: PARK, MinJeong
– fullname: FURUICHI, Noriyuki
– fullname: EMURA, Takashi
– fullname: SAKAMOTO, Hiroshi
– fullname: ASOH, Kohsuke
– fullname: HONG, WooSang
BookMark eNrjYmDJy89L5WQQCXENCXJ0jnT28XRWcPb3DfAP9XPhYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkZGxgZmpuYWjobGxKkCAM7YIW8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022306578A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022306578A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:14:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022306578A13
Notes Application Number: US202016862125
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220929&DB=EPODOC&CC=US&NR=2022306578A1
ParticipantIDs epo_espacenet_US2022306578A1
PublicationCentury 2000
PublicationDate 20220929
PublicationDateYYYYMMDD 2022-09-29
PublicationDate_xml – month: 09
  year: 2022
  text: 20220929
  day: 29
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Chugai Seiyaku Kabushiki Kaisha
RelatedCompanies_xml – name: Chugai Seiyaku Kabushiki Kaisha
Score 3.4303937
Snippet A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SUGARS
Title TETRACYCLIC COMPOUND
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220929&DB=EPODOC&locale=&CC=US&NR=2022306578A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUmzSAUWvWa6yYmGRromycAsZWGRZK5rnpxqaJpoYGGeBF5N6Otn5hFq4hVhGsHEkAPbCwM-J7QcfDgiMEclA_N7Cbi8LkAMYrmA11YW6ydlAoXy7d1CbF3UoL1jIyMDYHWv5uJk6xrg7-LvrObsbBsarOYXBJYDXZJubuEI7CuxghrSoJP2XcOcQPtSCpArFTdBBrYAoHl5JUIMTKl5wgyczrC714QZOHyhU95AJjT3FYswiIS4hgQ5Okc6-3g6Kzj7-wb4h_q5iDIou7mGOHvoAo2Ph_smPjQY2S3GYgwswH5-qgSDgoWpmbFxskWimbFZmollomVSqqFRGrD7ZpZmkJqWYpkkySCDzyQp_NLSDFwgLmipg5GlDANLSVFpqiywPi1JkgMHAwDxrHX4
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNW8VH1YKSWzCPNtkcgrSbhFTzok2knkKSbkCQWmzEv-9kSbWn3pYdGGYXvhm-3XkAPCxLwtD1amKRyYo4LBBShOS6qBdMHmUS0XOeTegHmpsMnxejRQs-trUwvE_oD2-OiIgqEO8V99fr_0csi-dWbh7zd9z6fHJi0xIadqwoEoZ7wZqYdhRaIRUoNZO5EMy4rB6SrpMxcqUDHUkhJ0uvk7ouZb0bVJwTOIxQ36o6hRZbdaFDt7PXunDkN1_euGzQt-lBL7bj2Zi-UW9KBzT0ozAJrDO4d-yYuiKqT_9OkybzXVvUc2gjz2cXMCAjTVULkmmqVg6NzMiZrJRI37RSYuXSyC-hv0_T1X7xHXTc2PdSbxq8XMNxLarTHhSjD-3q65vdYGyt8lt-Jb-aCnji
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TETRACYCLIC+COMPOUND&rft.inventor=ONO%2C+Yoshiyuki&rft.inventor=ISHII%2C+Nobuya&rft.inventor=MORIKAMI%2C+Kenji&rft.inventor=KAWADA%2C+Hatsuo&rft.inventor=KATO%2C+Yasuharu&rft.inventor=KINOSHITA%2C+Kazutomo&rft.inventor=ITO%2C+Toshiya&rft.inventor=OIKAWA%2C+Nobuhiro&rft.inventor=PARK%2C+MinJeong&rft.inventor=FURUICHI%2C+Noriyuki&rft.inventor=EMURA%2C+Takashi&rft.inventor=SAKAMOTO%2C+Hiroshi&rft.inventor=ASOH%2C+Kohsuke&rft.inventor=HONG%2C+WooSang&rft.date=2022-09-29&rft.externalDBID=A1&rft.externalDocID=US2022306578A1